Table 4.
Antibiotic | ESBL (N = 308) | non- ESBL (N = 132) | P value | ||
---|---|---|---|---|---|
AMC | 308 | 100% | 43 | 32.6% | < 0.001 |
CRO | 308 | 100% | 35 | 26.5% | < 0.001 |
CAZ | 308 | 100% | 2 | 1.5% | < 0.0001 |
FOX | 30 | 9.7% | 5 | 3.7% | 0.06 |
GEN | 225 | 73% | 13 | 9.8% | < 0.001 |
AK | 90 | 29.2% | 0 | 0% | 0.02 |
IPM | 0 | 0% | 0 | 0% | – |
CIP | 90 | 29.2% | 0 | 0% | 0.02 |
NIT | 88 | 28.5% | 22 | 16.6% | 0.08 |
MDR | 88 | 28.5% | 2 | 1.5% | 0.04 |
AMC amoxicillin clavulanic acid, CRO ceftriaxone, CAZ ceftazidime, FOX cefoxitin, CN gentamicin, AK amikacin, IPM imipenem, CIP ciprofloxacin, F nitrofurantoin